Drug targeting systems for cancer therapy: Nanotechnological approach

Progress in cancer treatment remains challenging because of the great nature of tumor cells to be drug resistant. However, advances in the field of nanotechnology have enabled the delivery of drugs for cancer treatment by passively and actively targeting to tumor cells with nanoparticles. Dramatic improvements in nanotherapeutics, as applied to cancer, have rapidly accelerated clinical investigations. In this review, drug-targeting systems using nanotechnology and approved and clinically investigated nanoparticles for cancer therapy are discussed. In addition, the rationale for a nanotechnological approach to cancer therapy is emphasized because of its promising advances in the treatment of cancer patients. © 2014 Bentham Science Publishers.

Dergi Adı Mini-Reviews in Medicinal Chemistry
Dergi Cilt Bilgisi 14
Dergi Sayısı 13
Sayfalar 1048 - 1054
Yayın Yılı 2014
Eser Adı
[dc.title]
Drug targeting systems for cancer therapy: Nanotechnological approach
Yazar
[dc.contributor.author]
Aydın R.S.T.
Yayın Yılı
[dc.date.issued]
2014
Yayıncı
[dc.publisher]
Bentham Science Publishers B.V.
Yayın Türü
[dc.type]
article
Özet
[dc.description.abstract]
Progress in cancer treatment remains challenging because of the great nature of tumor cells to be drug resistant. However, advances in the field of nanotechnology have enabled the delivery of drugs for cancer treatment by passively and actively targeting to tumor cells with nanoparticles. Dramatic improvements in nanotherapeutics, as applied to cancer, have rapidly accelerated clinical investigations. In this review, drug-targeting systems using nanotechnology and approved and clinically investigated nanoparticles for cancer therapy are discussed. In addition, the rationale for a nanotechnological approach to cancer therapy is emphasized because of its promising advances in the treatment of cancer patients. © 2014 Bentham Science Publishers.
Kayıt Giriş Tarihi
[dc.date.accessioned]
2019-12-23
Açık Erişim Tarihi
[dc.date.available]
2019-12-23
Yayın Dili
[dc.language.iso]
eng
Konu Başlıkları
[dc.subject]
Cancer
Konu Başlıkları
[dc.subject]
Drug
Konu Başlıkları
[dc.subject]
Drug delivery
Konu Başlıkları
[dc.subject]
Nanoparticles
Konu Başlıkları
[dc.subject]
Nanotechnology
Konu Başlıkları
[dc.subject]
Polimeric
Konu Başlıkları
[dc.subject]
Targeting
Konu Başlıkları
[dc.subject]
Therapeutics
Haklar
[dc.rights]
info:eu-repo/semantics/closedAccess
ISSN
[dc.identifier.issn]
1389-5575
İlk Sayfa Sayısı
[dc.identifier.startpage]
1048
Son Sayfa Sayısı
[dc.identifier.endpage]
1054
Dergi Adı
[dc.relation.journal]
Mini-Reviews in Medicinal Chemistry
Dergi Sayısı
[dc.identifier.issue]
13
Dergi Cilt Bilgisi
[dc.identifier.volume]
14
Tek Biçim Adres
[dc.identifier.uri]
https://hdl.handle.net/20.500.12628/5203
Görüntülenme Sayısı ( Şehir )
Görüntülenme Sayısı ( Ülke )
Görüntülenme Sayısı ( Zaman Dağılımı )
Görüntülenme
149
09.12.2022 tarihinden bu yana
İndirme
1
09.12.2022 tarihinden bu yana
Son Erişim Tarihi
18 Temmuz 2024 04:37
Google Kontrol
Tıklayınız
cancer treatment therapy nanoparticles advances because nanotechnology investigated drug-targeting clinically systems approved discussed addition Progress rationale nanotechnological approach emphasized promising patients Bentham Science Publishers review improvements remains challenging nature resistant However enabled delivery investigations passively
6698 sayılı Kişisel Verilerin Korunması Kanunu kapsamında yükümlülüklerimiz ve çerez politikamız hakkında bilgi sahibi olmak için alttaki bağlantıyı kullanabilirsiniz.

creativecommons
Bu site altında yer alan tüm kaynaklar Creative Commons Alıntı-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır.
Platforms